UTRECT, The Netherlands and PHILADELPHIA, Feb. 06, 2023 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (LVTX), an immuno-oncology company focused on developing its proprietary Gammabody™ platform of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results